Rocket Pharmaceuticals Inc (RCKT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Rocket Pharmaceuticals Inc   (NASDAQ: RCKT)


Rocket Pharmaceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Rocket Pharmaceuticals Inc's ROI in the second quarter of 2026?
Rocket Pharmaceuticals Inc recorded a cumulative net loss of $-17 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -5.4%.

Within the Healthcare sector 131 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2226 to 3761.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -22.79 % -24.31 % -15.48 % -6.28 % -15.54 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 379 261 300 337 378
Return On Investment (TTM) -5.4 % -65.66 % -61.53 % -58.86 % -62.22 %
RCKT's Overall Ranking # 3761 # 2226 # 2803 # 3541 # 3102
Seq. Investment Change TTM 0.12 % -12.05 % -11.41 % -1.02 % -1.85 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -17 -209 -223 -241 -257

RCKT Company Profile >> Back to RCKT Roi Comparisons >> See Annual RCKT Return On Investment



Return On Investment RCKT's Ranking
Within: No.
Industry # 45
Sector # 132
Overall # 3761

Return On Investment Statistics
High Average Low
-25.84 %
-43.38 %
-65.11 %
(Mar 31 2020)   (Mar 31 2026)



  News about Rocket Pharmaceuticals Inc Return on Investment ROI

Rocket Pharmaceuticals Bolsters Leadership Team with Appointment of Aaron Ondrey as CFO and Pursues Growth Strategy

March 26, 2024



Rocket Pharmaceuticals Inc. has recently made significant changes to its corporate leadership team, with the appointment of Aaron Ondrey as Chief Financial Officer (CFO). The company, a leading late-stage biotechnology firm focused on developing genetic therapies for rare disorders, aims to strengthen its position in the market and meet the high unmet medical needs of patients.
The appointment of Aaron Ondrey as CFO indicates Rocket Pharmaceuticals commitment to ensuring financial stability and sustainable growth. With his extensive experience and expertise in financial management, Ondrey will play a vital role in overseeing the company s financial operations and shaping its financial strategy.





Financial Statements
Rocket Pharmaceuticals Inc's II. Quarter Investments $ 379 Millions RCKT's Balance sheet
Rocket Pharmaceuticals Inc's II. Quarter Income $ 123 Millions Quarterly RCKT's Income Statement
RCKT's Income by Division See RCKT's Income by Division


RCKT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 300 487 518 513 475
Y / Y Investment Growth -38.35 % -5.95 % 1.01 % 7.96 % -11.83 %
Net Income in Millions -223 -259 -246 -222 -169
Y / Y Net Income Growth - - - - -
Annual Return On Investment -74.31 % -53.13 % -47.43 % -43.28 % -35.6 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RCKT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RCKT's Competitors
Subscribers only: Roi for Rocket Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for RCKT's Customers

Other Ratios
RCKT's Roa RCKT's Inventory Turnover Ratio RCKT's Growth Rates RCKT's Dividend Statistics
RCKT's Profitability Ratios RCKT's Asset Turnover Ratio RCKT's Dividend Growth
RCKT's Roe RCKT's Valuation Ratios RCKT's Financial Strength Ratios RCKT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-12T06:14:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.